Adial Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADIL and other ETFs, options, and stocks.

About ADIL

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist.

CEO

Cary J. Claiborne

CEOCary J. Claiborne

Employees

Employees18

Headquarters

Charlottesville, Virginia

HeadquartersCharlottesville, Virginia

Founded

2010

Founded2010

Employees

Employees18

ADIL Key Statistics

Market cap

7.52M

Market cap7.52M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

104.45K

Average volume104.45K

High today

$0.29

High today$0.29

Low today

$0.27

Low today$0.27

Open price

$0.2783

Open price$0.2783

Volume

35.77K

Volume35.77K

52 Week high

$3.05

52 Week high$3.05

52 Week low

$0.24

52 Week low$0.24

ADIL Earnings

-$0.30

-$0.20

-$0.10

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

-$0.18 per share

Estimated-$0.18 per share

Actual

-$0.12 per share

Actual-$0.12 per share

Adial Pharmaceuticals

Why Robinhood?

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. Show more

ADIL Key Statistics

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist.